RS Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$479K Hold
6,084
﹤0.01% 345
2016
Q1
$438K Sell
6,084
-2,254
-27% -$171K ﹤0.01% 340
2015
Q4
$703K Buy
8,338
+206
+3% +$17.1K 0.01% 302
2015
Q3
$681K Hold
8,132
0.01% 313
2015
Q2
$679K Sell
8,132
-1,660
-17% -$126K 0.01% 324
2015
Q1
$711K Sell
9,792
-500
-5% -$35.6K 0.01% 328
2014
Q4
$710K Buy
10,292
+500
+5% +$33.8K 0.01% 334
2014
Q3
$635K Sell
9,792
-1,600
-14% -$101K 0.01% 348
2014
Q2
$708K Buy
11,392
+1,000
+10% +$59.7K 0.01% 349
2014
Q1
$612K Buy
+10,392
New +$580K ﹤0.01% 350

Other funds holding LLY

RS Investment Management's LLY Position: Q2 2016 in Review

RS Investment Management held its Eli Lilly (LLY) position steady in Q2 2016 at 6,084 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

RS Investment Management first reported a position in LLY in Q1 2014 and has held it in 10 quarters since. The position peaked at $711K in Q1 2015. 1,180 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

  • RS Investment Management held 6,084 shares of Eli Lilly worth $479K as of Q2 2016.
  • RS Investment Management left its Eli Lilly share count unchanged in Q2 2016.
  • Eli Lilly made up ﹤0.01% of RS Investment Management's portfolio in Q2 2016, its #345 holding.
  • RS Investment Management first reported a position in Eli Lilly in Q1 2014 and has held it in 10 quarters since.
  • RS Investment Management's Eli Lilly position peaked at $711K in Q1 2015.
  • 1,180 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.